C161998Level 6
Paclitaxel/Rituximab/Topotecan Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of paclitaxel, rituximab, and topotecan that may be used in the treatment of relapsed, refractory non-Hodgkin lymphoma (NHL).
**Synonyms:** - Paclitaxel-Rituximab-Topotecan - Paclitaxel-Topotecan-Rituximab - Paclitaxel/Rituximab/Topotecan - Paclitaxel/Topotecan/Rituximab - TT-R - TT-R - TTR - TTR (rituximab-abbs) - TTR (rituximab-arrx) - TTR (rituximab-blit) - TTR (rituximab-pvvr) - TTR (rituximab-rite) - TTR (rituximab-rixa) - TTR (rituximab-rixi) - Taxol/Topotecan/Rituximab
GET
/api/v1/systems/nci_thesaurus/nodes/C161998Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.